Vendor, Exeter, GBR
University of Exeter
UEI ZNQ1VJLJQ827, CAGE U04U1
4 awards and $1,391,025 obligated between January 29, 2024 and September 25, 2026, 75% under full and open competition, against 2.0 offers on average where reported. 2 of the awards trace back to a SAM.gov solicitation on this site.
Industries
NAICS on the awards, by dollars.
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | $1,366,275 |
| Testing Laboratories and ServicesNAICS 541380 | $24,750 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 3 |
| Competed Under SAP | 1 |
| Delivery Order | 2 |
| Purchase Order | 1 |
Solicitations it won
SAM.gov opportunities whose award USAspending attributes to this vendor.
- Notice of Ordering Period Extension-Clinical Evaluation of Phenserine Tartrate Extended Controlled Release Tablet
National Institutes of Health, National Institutes of Health Nida
PresolicitationNAICS 54199075N95024D00002Awarded to University of Exeter for $1,988,692
Posted Jul 152 publications
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N95024F00001Delivery Order, January 31, 2024, Full and Open Competition | National Institutes of Health NidaNational Institutes of Health | Clinical Evaluation of Phenserine Tartrate Extended Controlled Release Tablet (Ecrt) Formulation in Early Mild Alzheimer'S Disease and Mild NAICS 541990, PSC B504 | $1,242,771 |
| 75N98026F00001Delivery Order, September 25, 2026, Full and Open Competition | National Institutes of Health OlaoNational Institutes of Health | Alzheimer Efficacy Study; Clinical Evaluation of Phenserine Tartrate Extended Controlled Release Tablet (Ecrt) Formulation in Early Mild AlzNAICS 541990, PSC B504 | $123,504 |
| 75N95D24P00115Purchase Order, September 6, 2024, Competed Under SAP, 1 offers | National Institutes of Health NiaNational Institutes of Health | Laboratory Support Services - Quantification of Phenserine in Human Plasma SamplesNAICS 541380, PSC Q301 | $24,750 |
| 75N95024D00002January 29, 2024, Full and Open Competition, 3 offersSolicitation | National Institutes of Health NidaNational Institutes of Health | Clinical Evaluation of Phenserine Tartrate Extended Controlled Release Tablet (Ecrt) Formulation in Early Mild Alzheimer'S Disease and Mild NAICS 541990, PSC B504 | $0 |
- Product and service codes
- B504 Chemical/Biological Studies and AnalysisQ301 Reference Laboratory Testing
- Transactions
- 8 across 4 awards